Posts

Showing posts from February, 2022

Targeting Merck? Leverage Their Actionable Org Chart for Faster Closures.

The impediments of prospecting with Fortune 500 companies in the pharmaceutical domain are way too many. Starting from a lengthy sales cycle to immense consumption of sales, management and marketing team’s bandwidth, deciding and executing the right marketing approach - reasons are countless. However, for the new-age B2B marketer the most critical challenge is to come to grips with ‘multiple layers of approvals’ even for a single purchase in such big enterprises. For example, in a Fortune 500 company like Merck, ‘perspectives like Data, Security, Legal, IT, Finance, HR, Management, Business Units, and Procurement all are equal stakeholders in any important decision making.’  The question here is - How can a B2B marketing team create multiple connections in a company like Merck and ensure faster sales closure while tracking the progress?     Sales intelligence experts have unleashed a perfect solution to this through actionable organization charts of Fortune 500 companies ...